Clinical trial
Personalized Transcranial Magnetic Stimulation for Metabolic Dysfunction and Alcohol-Related Liver Disease (MetALD): A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
NCT07399600 is registered in ClinicalTrials.gov with The Affiliated Hospital of Hangzhou Normal University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Transcranial Magnetic Stimulation for Metabolic Dysfunction and Alcohol-Related Liver Disease (MetALD): A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- Lead sponsor
- The Affiliated Hospital of Hangzhou Normal University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 1, 2026
- Completion date
- December 31, 2027
- Enrollment
- 105 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.